Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kutteh, W. H.
Right arrow Articles by Scott, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kutteh, W. H.
Right arrow Articles by Scott, R. T., Jr
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 11, 2886-2890, November 1999
© 1999 European Society of Human Reproduction and Embryology

Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction *

William H. Kutteh1,4, William B. Schoolcraft2 and Richard T. Scott, Jr3

1 Room D324, Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, 956 Court Avenue, University of Tennessee, Memphis, Tennessee 38163–2116, 2 Colorado Center for Reproductive Medicine, Englewood, CO and 3 Saint Barnabus Medical Center, Livingston, NJ, USA

The purpose of this study was to determine the association of antibodies to thyroglobulin and thyroid peroxidase and pregnancy outcome in women undergoing assisted reproductive techniques. The study included three centres and retrospectively evaluated patient sera for antithyroid antibodies, then related the results to pregnancy outcome. Enzyme-linked immunosorbant assays for thyroglobulin and thyroid peroxidase antibodies were performed using two different commercially available kits. Controls included 200 healthy women of reproductive age. Women (n = 873) who were undergoing assisted reproductive techniques for pelvic adhesions, endometriosis, ovarian dysfunction, or unexplained/other were included. All women utilized a standard regimen of gonadotrophin releasing hormone agonist down-regulation followed by ovulation induction. Embryos were cultured for 3 days, at which time embryo transfer occurred. Statistical analysis utilized the two-tailed Fisher's exact test. Antithyroid antibodies were positive in 143 of 873 (16.4%) women undergoing assisted reproductive techniques while 29 of 200 (14.5%) normal controls were positive (not significant). Deliveries were achieved in 396 of 730 (54.2%) of women who had no thyroid antibodies versus 78 of 143 (54.5%) of women who had thyroid antibodies (not significant). No difference in biochemical pregnancies (not significant) or clinical pregnancy losses (not significant) were detected. Antithyroid antibodies were found no more frequently in women undergoing assisted reproductive techniques than in normal controls. There were no differences in pregnancy outcome based on antithyroid antibody positivity in women undergoing assisted reproductive techniques. These data do not support the testing or treatment for antithyroid antibodies of women undergoing assisted reproductive techniques.

Key words: antithyroid antibodies/autoimmunity/infertility/in-vitro fertilization

4 To whom correspondence should be addressed

* This paper was presented at the 54th Annual Meeting of the American Society for Reproductive Medicine, San Francisco, CA, USA, October 4–9, 1998.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
J. Bellver, S. R. Soares, C. Alvarez, E. Munoz, A. Ramirez, C. Rubio, V. Serra, J. Remohi, and A. Pellicer
The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion
Hum. Reprod., February 1, 2008; 23(2): 278 - 284.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Subsection Reports
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s8 - s47.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Abalovich, N. Amino, L. A. Barbour, R. H. Cobin, L. J. De Groot, D. Glinoer, S. J. Mandel, and A. Stagnaro-Green
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8_suppl): s1 - s47.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Negro, T. Mangieri, L. Coppola, G. Presicce, E. C. Casavola, R. Gismondi, G. Locorotondo, P. Caroli, A. Pezzarossa, D. Dazzi, et al.
Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study
Hum. Reprod., June 1, 2005; 20(6): 1529 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Poppe, D. Glinoer, H. Tournaye, P. Devroey, A. van Steirteghem, L. Kaufman, and B. Velkeniers
Assisted Reproduction and Thyroid Autoimmunity: An Unfortunate Combination?
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4149 - 4152.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. S. Ghazeeri and W. H. Kutteh
Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia
Hum. Reprod., October 1, 2001; 16(10): 2130 - 2135.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.